Coya Therapeutics Total Liabilities

Coya Therapeutics (COYA) currently reports a total liabilities of $4B as of June 2026. That compares with $5.1B in the prior-year period — down 21.6% year over year. Use the charts on this page to explore Coya Therapeutics's total liabilities history and peer comparisons.

Coya Therapeutics's total liabilities decreased from $5.1B to $4B — a 21.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Coya Therapeutics reported $4B in total liabilities as of June 2026. That compares with $5.1B in the prior-year period — down 21.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Coya Therapeutics, and consider following COYA for alerts when major investors trade the stock.